Abstract
Intensive research and major technical advances in the last decade have resulted in a remarkable improvement in transfusion supportive care which has significantly contributed to the increased survival now achievable in patients with leukaemia and aplastic anaemia. Platelet transfusions are now available in almost all hospitals, while granulocyte transfusions, previously used only in cancer centres, are now being dispensed by many regional blood transfusion centres in the United States. A number of reviews dealing with donor selection and safety, collection methodology and clinical guidelines for cell component use have been published in the last few years
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
